Clinical Trials Browser

Phase 1/2 × OTHER × Castrate-resistant Prostate Cancer × Clear all

NCT01717898 2018-03-27

A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Phase 1/2 Terminated

6 enrolled 5 charts

Castrate-resistant Prostate Cancer